Researchers at Oregon Health & Science University have uncovered how a molecule found on certain bacteria may drive blood clotting in sepsis, a life-threatening condition that causes about 8 million deaths per year.
Jan 17, 2025
0
26
Cancer remains one of the most complex diseases, with its diverse molecular profiles and cellular compositions posing significant challenges for treatment. Traditional methods of cancer research, such as two-dimensional cell ...
Jan 17, 2025
0
0
A University of Massachusetts Amherst-Ernest Pharmaceuticals team of scientists has made "exciting," patient-friendly advances in developing a non-toxic bacterial therapy, BacID, to deliver cancer-fighting drugs directly ...
Jan 16, 2025
0
64
Many physicians are now using algorithms that consider a patient's sex, like heart disease risk assessment tools, to help with clinical decision-making. Reliance on these algorithms may result in men and women receiving different ...
Jan 16, 2025
0
10
Genetic changes are a significant cause of infertility, impacting over 15% of the global population. TLE6, a major protein involved in early embryonic development, is known to affect female fertility. In a recent study, researchers ...
Jan 16, 2025
0
0
Within a few days of being born, more than 300,000 Australian babies a year have a spot of their blood analyzed to screen for a range of serious but treatable health conditions.
Jan 16, 2025
0
0
Most treatments being pursued today to protect against Alzheimer's disease focus on amyloid plaques and tau tangles that accumulate in the brain, but new research from Mass General Brigham and Washington University School ...
Jan 15, 2025
0
108
The Tomosynthesis Mammographic Imaging Screening Trial (TMIST) has reached its enrollment goal of 108,508 women, as announced today by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN).
Jan 15, 2025
0
0
Two new compounds may be able to treat retinitis pigmentosa, a group of inherited eye diseases that cause blindness. The compounds, described in a study published January 14 in the open-access journal PLOS Biology by Beata ...
Jan 14, 2025
0
9
A University of the Basque Country (UPV/EHU) study proves that the WIN55.212-2 drug protects the brain and reverses the initial cognitive damage caused by dementia.
Jan 14, 2025
0
0
